Sustained inflammation and differential expression of interferons type I and III in PVM-infected interferon-gamma (IFNγ) gene-deleted mice

Virology

Volumn 468-470, Issue , 2014, Pages 140-149

  Glineur, Stephanie F ^a,d   Bowen, Aaron B ^a,e   Percopo, Caroline M ^a   Garcia Crespo, Katia E ^a,f   Dyer, Kimberly D ^a   Ochkur, Sergei I ^b   Lee, Nancy A ^b   Lee, James J ^b   Domachowske, Joseph B ^c   Rosenberg, Helene F ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

^d UCB PHARMA   (Belgium)

^e University of Colorado Denver Anschutz Medical Campus ^*  (United States)

^f AAAS   (United States)

Author keywords

Eosinophils; Inflammation; Interferon; Pneumovirus

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; BETA INTERFERON; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; INTERFERON TYPE III; INTERLEUKIN 28A; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; UNCLASSIFIED DRUG; CHEMOATTRACTANT; CXCL3 CHEMOKINE; INTERFERON LAMBDA 3; CYTOKINE; INTERFERON-LAMBDA PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EOSINOPHIL INFILTRATION; EX VIVO STUDY; GENE DELETION; HISTOPATHOLOGY; INFLAMMATION; INTRACELLULAR SIGNALING; LEUKOCYTE MIGRATION; LUNG INFILTRATE; LUNG PARENCHYMA; MOUSE; MURINE PNEUMONIA VIRUS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRAL CLEARANCE; VIRUS REPLICATION; WEIGHT REDUCTION; WILD TYPE; AIRWAY; ANIMAL CELL; CELL INFILTRATION; EOSINOPHIL; GENE; IFN GAMMA GENE; MICROBIAL KINETICS; PNEUMOVIRUS INFECTION; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; METABOLISM; PATHOLOGY;

MUS; PNEUMOVIRUS; POTATO VIRUS M;

ANIMALS; CYTOKINES; EOSINOPHILS; GENE DELETION; GENE EXPRESSION REGULATION, VIRAL; INFLAMMATION; INTERFERON TYPE I; INTERFERON-BETA; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MURINE PNEUMONIA VIRUS; PNEUMOVIRUS INFECTIONS;

EID: 84906772363     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.07.039     Document Type: Article

References (70)

1. Akdis M., Burgler S., Crameri R., Elwegger T., Fujita H., Gomez E., Klunker S., Meyer N., O'Mahony L., Palomares O., Rhyner C., Ouaked N., Schaffartzik A., Van De Veen W., Zeller S., Zimmermann M., Akdis C.A. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J. Allergy Clin. Immunol. 2011, 127:701-721.
2. Aliberti J.C.S., Souto J.T., Marino A.P.M.P., Lannes-Vieira J., Teixeira M.M., Farber J., Gazzinelli R.T., Silva J.S. Modulation of chemokine production and inflammatory responses in interferon-gamma and tumor necrosis factor R1 deficient mice during Trypanosoma cruzi infection. Am. J. Pathol. 2001, 158:1433-1440.
3. Anh D.B., Faisca P., Desmecht D.J. Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L426-L435.
4. Bem R.A., Domachowske J.B., Rosenberg H.F. Animal models of human respiratory syncytial virus disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301:L148-L156.
5. Boelen A., Kwakkel J., Barends M., de Rond L, Dormans J., Kimman T. Effect of lack of interleukin-4, interleukin-12, interleukin-18 or the interferon-gamma receptor on virus replication, cytokine response and lung pathology during respiratory syncytial virus infection in mice. J. Med. Virol. 2002, 66:552-560.
6. Bonville C.A., Easton A.J., Rosenberg H.F., Domachowske J.B. Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J. Virol. 2003, 77:1237-1244.
7. Bonville C.A., Lau V.K., DeLeon J.M., Gao J.L., Easton A.J., Rosenberg H.F., Domachowske J.B. Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J. Virol. 2004, 78:7984-7989.
8. Bonville C.A., Bennett N.J., Koehnlein M., Haines D.M., Ellis J.A., DelVecchio A.M., Rosenberg H.F., Domachowske J.B. Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology 2006, 349:87-95.
9. Borchers A.T., Chang C., Gershwin M.E., Gershwin L.J. Respiratory syncytial virus: a comprehensive review. Clin. Rev. Allergy Immunol. 2013, 45:331-379.
10. Casanova J.L., Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 2002, 20:581-620.
11. Costa V.V., Fagundes C.T., Valadao D.F., Cisalpino D., Dias A.C., Silveira K.D., Kangussu L.M., Avila T.V., Bonfim M.R., Bonaventura D., Silva T.A., Sousa L.P., Rachid M.A., Viera L.Q., Menezes G.B., de Paula A.M., Atrasheuskaya A., Ignatyev G., Teixeira M.M., Souza D.G. A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-gamma in host resistance to infection. PloS Negl. Trop. Dis. 2012, 6:e1663.
12. Coyle A.J., Tsuyuki S., Bertrand C., Huang S., Aguet M., Alkan S.S., Anderson G.P. Mice lacking the interferon-gamma receptor have an impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J. Immunol. 1996, 156:2680-2685.
13. Culley F.J., Pollott J., Openshaw P.J. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J. Exp. Med. 2002, 196:1381-1386.
14. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993, 259:1739-1742.
15. de Bruin A.M., Buitenhuis M., van der Sluijs K.F., van Gisbergen K.P.J.M., Boon L., Nolte M. Eosinophil differentiation in the bone marrow is inhibited by T cell-derived IFN-gamma. Blood 2010, 116:2559-2569.
16. Dent L.A., Strath M., Mellor A.L., Sanderson C.J. Eosinophilia in transgenic mice expressing interleukin-5. J. Exp. Med. 1990, 172:1425-1431.
17. Donnelly R.P., Kotenko S.V. Interferon-lambda: a new addition to an old family. J. Interferon Cytokine Res. 2010, 30:555-564.
18. Dorman S.E., Uzel G., Roesler J., Bradley J.S., Bastian J., Billman G., King S., Filie A., Schermerhorn J., Holland S.M. Viral infections in interferon-gamma receptor deficiency. J. Pediatr. 1999, 135:640-643.
19. Durbin R.K., Kotenko S.V., Durbin J.E. Interferon induction and function at the mucosal surface. Immunol. Rev. 2013, 255:25-39.
20. Dyer K.D., Moser J.M., Czapiga M., Siegel S.J., Percopo C.M., Rosenberg H.F. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J. Immunol. 2008, 181:4004-4009.
21. Dyer K.D., Moser J.M., Czapiga M., Siegel S.J., Percopo C.M., Rosenberg H.F. The pneumonia virus of mice (PVM) model of acute respiratory virus infection. Viruses 2012, 4:3494-3510.
22. Ellis J.A., Martin B.V., Waldner C., Dyer K.D., Domachowske J.B., Rosenberg H.F. Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice. Vaccine 2007, 25:1085-1095.
23. Empey K.M., Orend J.G., Peebles R.S., Egana L., Norris K.A., Oury T.D., Kolls J.K. Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection. PLoS One 2012, 7:e40499.
24. Fagundes C.T., Costa V.V., Cisalpino D., Amaral F.A., Souza P.R., Souza R.S., Ryffel B., Viera L.Q., Silva T.A., Atrasheuskaya A., Ignatyev G., Sousa L.P., Souza D.G., Teixeira M.M. IFN-gamma production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner. PloS Negl. Trop. Dis. 2011, 5:e1449.
25. Fernandez J.A., Tapia L., Palomino M.A., Larranaga C., Pena M., Jaramillo H. Plasma interferon-gamma, interleukin-10 and soluble markers of immune activation in infants with primary adenovirus (ADV) and respiratory syncytial virus (RSV) infection. Eur. Cytokine Netw. 2005, 16:35-40.
26. Frey S., Krempl C.D., Schmitt-Graff A., Ehl S. Role of T cells in virus control and disease after infection with pneumonia virus of mice. J. Virol. 2008, 82. (11619-27).
27. Gabryszewski S.J., Bachar O., Dyer K.D., Percopo C.M., Killoran K.E., Domachowske J.B., Rosenberg H.F. Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection. J. Immunol. 2011, 186:1151-1161.
28. Garcia-Crespo K.E., Chan C.C., Gabryszewski S.J., Percopo C.M., Rigaux P., Dyer K.D., Domachowske J.B., Rosenberg H.F. Lactobacillus priming of the respiratory tract: heterologous immunity and protection against lethal pneumovirus infection. Antivir. Res. 2013, 97:270-279.
29. Garofalo R.P., Hintz K.H., Hill V., Ogra P.L., Welliver R.C. Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J. Med. Virol. 2004, 73:289-294.
30. Garvey T.L., Dyer K.D., Ellis J.A., Boonville C.A., Foster B., Prussin C., Easton A.J., Domachowske J.B., Rosenberg H.F. Inflammatory responses to pneumovirus infection in IFNαβR gene-deleted mice. J. Immunol. 2005, 175:4735-4744.
31. Graham M.B., Dalton D.K., Giltinan D., Braciale V.L., Stewart T.A., Braciale T.J. Response to influenza infection in mice with targeted disruption in the interferon gamma gene. J. Exp. Med. 1993, 178:1725-1732.
32. Groom J.F., Luster A.D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 2011, 89:207-215.
33. Hardy R.D., Coalson J.J., Peters J., Chaparro A., Techasaensiri C., Cantwell A.M., Kannan T.R., Baseman J.B., Dube P.H. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. PloS One 2009, 4:e7562.
34. He S.H., Song C.H., Liu Z., Zhang H., Ma W., Zhou L.F., Mahmood T., Yang P.C. Eosinophil-derived interferon-lambda contributes to initiation of allergen-related inflammation in the intestine. Cytokine 2012, 58:186-192.
35. Heinze B., Frey S., Mordstein M., Schmitt-Graff A., Ehl S., Buchholz U.J., Collins P.L., Staeheli P., Krempl C.D. Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of type I and type III responses in vivo. J. Virol. 2011, 85:4071-4084.
36. Hu X., Paik P.K., Chen J., Yarilina A., Kockeritz L, Lu T.T., Woodgett J.R., Ivashkiv L.B. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 2006, 24:563-574.
37. Hu X., Ivashkiv L.B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-550.
38. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M. Immune response in mice that lack the interferon gamma receptor. Science 1993, 259:1742-1745.
39. Jewell N.A., Cline T., Mertz S.E., Smirnov S.V., Flano E., Schindler C., Grieves J.L., Durbin R.K., Kotenko S.V., Durbin J.E. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J. Virol. 2010, 84:11515-11522.
40. Johnson T.R., Mertz S.E., Gitiban N., Hammond S., LeGallo R., Durbin R.K., Durbin J.E. Role for innate IFNs in determining respiratory syncytial virus immunopathology. J. Immunol. 2005, 174:7234-7241.
41. Juntti H., Kokkonen J., Dunder T., Renko M., Karttunen R., Uhari M. Serum concentrations of interferon-gamma and intercellular adhesion molecule-1 eight years after an early respiratory syncytial virus infection. Clin. Exp. Allergy 2005, 35:59-63.
42. Kumar R.K., Foster P.S., Rosenberg H.F. Respiratory viral infection, epithelial cytokines and innate lymphoid cells in asthma exacerbations. J. Leukoc. Biol. 2014, (In press).
43. Lee Y.M., Miyahara N., Takeda K., Prpich J., Oh A., Balhorn A., Joetham A., Gelfand E.W., Dakhama A. IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 2008, 177:208-218.
44. Lee K.S., Cool C.D., van Dyk L.F. Murine gammaherpesvirus 68 infection of gamma interferon-deficient mice on a BALB/c background results in acute lethal pneumonia that is dependent on specific viral genes. J. Virol. 2009, 83:11397-11401.
45. Letuve S., Druilhe A., Grandsaigne M., Aubier M., Pretolani M. Involvement of caspases and of mitochondria in Fas ligation-induced eosinophil apoptosis: modulation by interleukin-5 and interferon-gamma. J. Leukoc. Biol. 2001, 70:767-775.
46. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 1994, 264:1918-1921.
47. Ochiai K., Ishihara C., Tomioka H. Signal transduction through interferon-gamma receptor on human eosinophils. Int. Arch. Allergy Immunol. 1999, 118:443-446.
48. Ochkur S.I., Kim J.D., Protheroe C.A., Colbert D., Moqbel R., Lacy P., Lee J.J., Lee N.A. The development of a sensitive and specific ELISA for mouse eosinophil peroxidase: assessment of eosinophil degranulation ex vivo and in models of human disease. J. Immunol. Methods 2012, 375:138-147.
49. Percopo C.M., Dubovi E.J., Renshaw R.W., Dyer K.D., Domachowske J.B., Rosenberg H.F. Canine pneumovirus replicates in mouse lung tissue and elicits inflammatory pathology. Virology 2011, 416:26-31.
50. Percopo C.M., Dyer K.D., Ochkur S.I., Luo J.L., Fischer E.R., Lee J.J., Lee N.A., Domachowske J.B., Rosenberg H.F. Activated mouse eosinophils protect against lethal respiratory virus infection. Blood 2014, 123:743-752.
51. Platanias L.C. Mechanisms of type I and type II interferon mediated signaling. Nat. Rev. Immunol. 2005, 5:375-386.
52. Pomeroy C., Delong D., Clabots C., Riciputi P., Filice G.A. Role of interferon-gamma in murine cytomegalovirus infection. J. Lab. Clin. Med. 1998, 132:124-133.
53. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008, 89:1-47.
54. Rauch I., Muller M., Decker T. The regulation of inflammation by interferons and their STATs. JAKSTAT 2013, 2:e23820.
55. Rosenberg H.F., Domachowske J.B. Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol. Lett. 2008, 118:6-12.
56. Rosenberg H.F., Dyer K.D., Foster P.S. Eosinophils: changing perspectives in health and disease. Nat. Rev. Immunol. 2013, 13:9-22.
57. Rudraraju R., Jones B.G., Sealy R., Surman S.L., Hurwitz J.L. Respiratory syncytial virus: current progress in vaccine development. Viruses 2013, 5:577-594.
58. Schroeder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004, 75:163-189.
59. Schwarze J., Cieslewicz G., Hamelmann E., Joetham A., Shultz L.D., Lamers M.C., Gelfand E.W. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J. Immunol. 1999, 162:2997-3004.
60. Shadman K.A., Wald E.R. A review of palivizumab and emerging therapies for respiratory syncytial virus. Expert Opin. Biol. Ther. 2011, 11:1455-1467.
61. Shoenborn J.R., Wilson C.B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007, 96:41-101.
62. Su S.B., Grajewski R.S., Luger D., Agarwal R.K., Silver P.B., Tang J., Tuo J., Chan C.C., Caspi R.R. Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency. Invest. Ophthalmol. Vis. Sci. 2007, 48:4616-4625.
63. Tabarani C.M., Bonville C.A., Suryadevara M., Branigan P., Wang D., Huang D., Rosenberg H.F., Domachowske J.B. Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 2013, e437-e442.
64. Thomson S.J.P., Goh F.G., Banks H., Krausgruber T., Kotenko S.V., Foxwell B.M.J., Udalova I.A. The role of transposable elements in the regulation of IFN-lambda1 gene expression. Proc. Natl. Acad. Sci. USA 2009, 106:11564-11569.
65. Tsai C.Y., Hu Z., Zhang W., Usherwood E.J. Strain-dependent requirement for interferon-gamma for respiratory control and immunotherapy in murine gammaherpesvirus infection. Viral Immunol. 2011, 24:273-280.
66. van den Broek MF, Muller U, Huang S, Zinkernagel RM, Aguet M. Immunedefence in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 1995, 148:5-18.
67. Walsh E.E. Respiratory syncytial virus infection in adults. Semin. Respir. Crit. Care Med. 2011, 32:423-432.
68. Walsh K.B., Teijaro J.R., Brock L.G., Fremgen D.M., Collins P.L., Rosen H., Oldstone M.B. Animal model of respiratory syncytial virus: CD8+ T cells cause cytokine storm that is chemically tractable by sphingosine-1-phsophate 1 receptor agonist therapy. J. Virol. 2014, 88:6281-6293.
69. Wohlleben G., Erb K.J. The absence of IFN-gamma leads to increased TH2 responses after influenza A virus infection characterized by an increase in CD4+ but not CD8+ T cells producing IL-4 or IL-5 in the lung. Immunol. Lett. 2004, 95:161-166.
70. Zhao L.L., Lotvall J., Linden A., Tomaki M., Sjostrand M., Bossios A. Prolonged eosinophil production after allergen exposure in IFN-gammaR KO mice is IL-5 dependent. Scand. J. Immunol. 2008, 67:480-488.